Definition and classification of cancer cachexia: an international consensus.
By K. Fearon, F. Strasser, S. Anker, I. Bosaeus, E. Bruera, R. Fainsinger, A. Jatoi, C. Loprinzi, N. Macdonald, G. Mantovani and 9 more. The Lancet Oncology, 2011
4,957 citations recorded by the source corpus.
Subfields: Pathology and Forensic Medicine, Physiology
View Paper: https://www.semanticscholar.org/paper/934c7b2bf206198fd93980814f422c70019d2c6a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pathology and Forensic Medicine
In Physiology
- Vickie E. Baracos
- P. Calder
- J. Morley
- P. Vaupel
- D. McMillan
- Jessica Lieffers
- Marjolein Visser
- S. Larsson
Citations in the corpus
- Nutrition and physical activity guidelines for cancer survivors (2012, background): “prevalence of malnutrition and weight loss varies widely across cancer types and stage at diagnosis.(10) Consuming enough calories to prevent additional weight loss is therefore vital for survivors at risk of unintentional weight loss, such as those who are already malnourished or those who receive ”
- Inflammation and sarcopenia: A systematic review and meta-analysis. (2017, neutral): “Contrary to our findings, a previous narrative review [12] distinguished sarcopenia and cachexia, which is defined as a multifactorial syndrome accompanied by anorexia and loss of muscle mass not fully reversed by nutritional support [38].”
- Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery (2012, methodology): “These cutoffs were accepted by an international consensus group on the diagnostic criteria for cancer cachexia (Fearon et al, 2011).”
- GLIM criteria for the diagnosis of malnutrition - A consensus report from the global clinical nutrition community. (2019, background): “Impairment of muscle strength and function are core phenomena in conditions like sarcopenia [15,16], cachexia [5,6], and frailty [20].”
- ESPEN guidelines on definitions and terminology of clinical nutrition. (2017, background): “Cachexia, as described in cancer, can progressively develop through various stages: pre-cachexia; cachexia; and refractory cachexia [16,17].”
- ESPEN expert group recommendations for action against cancer-related malnutrition. (2017, background): “Risk for cachexia and its worsening depends on factors such as cancer type and stage, extent of systemic inflammation, and degree of response to anticancer therapy [10,13].”
- Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. (2015, methodology): “However, using the cut-off value defined by an international consensus as the appropriate value to use to identify cancer cachexia [36], 80.”
- Sarcopenia: revised European consensus on definition and diagnosis (2018, background): “In particular, CT images of a specific lumbar vertebral landmark (L3) correlated significantly with whole-body muscle [94, 95].”